BIO’s CSO testifies at congressional hearing on PDUFA riders
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, BIO’s Chief Scientific Officer Dr. Cartier Esham told a House panel …
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »